HSA
ADAP

HBK Sorce Advisory’s Adaptimmune Therapeutics ADAP Stock Holding History

HBK Sorce Advisory’s Portfolio ADAP Stock Details ADAP Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Shares
Change % 		Capital Flow Portfolio Weight Portfolio Position
2023
Q1 		– Sell
-70,000
Closed -$65K – 587
2022
Q4 		$65K Buy
70,000
+35,000
+100% +$32.5K ﹤0.01% 709
2022
Q3 		$32K Buy
+35,000
New +$32K ﹤0.01% 533